(Q38442672)

3 September 2017

title

Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer (English)

1 reference

3 September 2017

1 reference

4

Michaela E McGree

1 reference

3 September 2017

5

Amy L Weaver

1 reference

3 September 2017

Jo Marie Tran Janco

1

1 reference

3 September 2017

Gretchen Glaser

2

1 reference

3 September 2017

Bohyun Kim

3

1 reference

3 September 2017

William A Cliby

6

1 reference

3 September 2017

Sean C Dowdy

7

1 reference

3 September 2017

Jamie N Bakkum-Gamez

8

1 reference

3 September 2017

language of work or name

English

0 references

publication date

22 April 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

138

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

70-77

1 reference

Cytoreductive surgery for ovarian cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Epithelial ovarian carcinoma: principles of primary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

To predict or not to predict? The dilemma of predicting the risk of suboptimal cytoreduction in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.013

10.1016/J.YGYNO.2015.04.013

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference